查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1870866

骨再生材料市场按材料类型、应用、最终用户和供应类型划分－2025-2032年全球预测

Bone Regeneration Material Market by Material Type, Application, End User, Delivery Form - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，骨再生材料市场将成长至 111.5 亿美元，复合年增长率为 7.97%。

关键市场统计数据
基准年 2024 60.3亿美元
预计年份：2025年 65.2亿美元
预测年份 2032 111.5亿美元
复合年增长率 (%) 7.97%

策略性介绍，概述了生物材料创新、临床需求、监管挑战和商业化重点在骨骼修復领域的整合。

骨再生材料已从最初的简易移植物和基础支架发展成为如今涵盖生物材料、生物製药和递送系统的复杂产品组合，能够应对牙科、整形外科、脊椎和创伤护理等领域的各种临床挑战。生物材料科学、生物增强和积层製造等技术的整合推动了该领域的发展，临床医生也日益追求可预测的治疗效果、更低的併发症率和更简化的工作流程。鑑于复杂的监管环境和报销体系，研发人员必须在创新、可製造性和临床证据的累积之间取得平衡，才能实现产品的持续应用。

清楚说明了技术、临床、监管和价值基础设施的变革性转变，这些转变正在重塑骨再生产品的开发和应用。

随着材料化学、生物增强和精密製造领域的创新融合，骨再生材料领域正经历变革性的转变，产品性能和临床工作流程也随之重塑。生物陶瓷和复合支架与聚合物基质和生物增强剂协同作用，催生出旨在复製天然骨骼层级结构和生物讯号传导的混合解决方案。同时，积层製造技术和患者特异性设计使得植入和支架的解剖结构更加匹配，从而改善了植入物的贴合度，缩短了手术时间，并促进了更可预测的癒合过程。

对2025年美国关税在营运、临床、监管和供应链等多方面的影响进行深入分析

2025年对某些医疗材料和组件加征关税，为骨再生价值链上的相关人员带来了许多营运和策略挑战。在营运方面，依赖进口原料（例如高纯度陶瓷粉、某些聚合物原料和生物试剂）的製造商正面临投入成本上升和重新审视供应商的压力。这些压力迫使采购部门实现供应商多元化，考虑将部分职能迁回国内，并重新谈判长期供应合同，以确保供应的连续性和可预测的成本结构。

综合考虑材料类型、临床应用、最终用户环境和剂型等因素，进行全面的观点，以明确产品策略和推广路径。

基于细分市场的洞察表明，材料类型、应用领域、终端用户环境和剂型共同决定了骨再生领域的产品性能要求和商业化路径。在材料类型方面，羟基磷灰石、磷酸三钙、双相磷酸钙和硫酸钙等陶瓷材料因其骨传导性和结构支撑性而备受青睐；复合材料则将陶瓷相和聚合物相结合，以实现机械性能和生物活性的平衡。在需要承载强度的领域，金属仍扮演重要角色；天然生长因子则能引入生物讯号以刺激再生。聚合物具有可调控的降解速率和操作性能；胶原蛋白、聚己内酯、Polyglycolic和聚乳酸是影响细胞相互作用和吸收特性的典型例子。

详细的区域分析突显了每个全球区域不同的临床需求驱动因素、监管复杂性和供应链策略

骨再生领域的区域趋势表明，影响技术应用、监管应对和供应链配置的因素​​多种多样，既有驱动因素，也有障碍。在美洲，先进的外科基础设施和较高的择期手术率影响临床需求，为高端生物材料和复合材料产品的应用创造了有利环境。同时，支付方和综合医疗网络推动了严格的证据要求和成本控制策略。欧洲、中东和非洲地区的情况则更为复杂，各国不同的报销政策、部分市场的集中采购以及多样化的监管路径，既带来了机会，也造成了市场碎片化。为了应对这些复杂情况，製造商通常会采取针对特定国家的策略和伙伴关係。

对骨再生材料领域主要企业和新兴挑战者的竞争动态、创新策略和业务重点进行综合分析

骨再生领域由成熟的生物材料製造商、专业的医疗设备公司以及致力于生物增强和支架工程的新兴生物技术公司组成。主要企业凭藉整合的产品组合脱颖而出，这些产品组合融合了成熟的支架平台和生物增强剂、专有的加工技术以及检验的灭菌和包装方法，从而确保产品性能。投资于卓越的製造工艺，包括品管系统和可扩展的无菌工艺，是寻求从利基产品拓展到全院应用的企业的通用目标。

为实现可持续的市场主导地位，提出整合材料创新、临床证据产生、供应链韧性和监管合规性的实用策略建议

产业领导者应采取多管齐下的策略，平衡对深层材料科学的投入、切实可行的商业化应用以及供应链的韧性。首先，应优先开发兼具优异机械性能和生物讯号的混合解决方案，重点关注适用于多种适应症的平台，以最大限度地提高临床评估投资回报。同时，应投资于将临床结果与卫生经济学终点联繫起来的证据生成工作，并加强与支付方和医院采购部门的对话，以基于整体医疗价值来论证其高端定位的合理性。

本研究采用透明的混合方法研究框架，结合了临床访谈、技术文献综述和跨领域检验，以确保研究结果具有可操作性。

本分析的调查方法整合了初级和二级研究阶段、专家访谈以及跨部门检验，以确保得出平衡且实用的结论。初级资料输入包括对牙科、整形外科、脊椎和创伤专科的临床医生、医院和门诊中心的采购和供应链管理人员以及监管和品质保证专业人员的结构化访谈，以深入了解实践障碍和系统层面的考量。这些定性资料与技术文献、产品应用和已发表的临床研究相结合，以三角验证材料性能特征和临床结果。

总之，这项综合性综述强调了将科学创新、卓越营运和临床证据相结合，以在骨再生领域取得永续成果的必要性。

总之，骨再生材料领域正处于转折点，材料科学、生物增强技术和供应链策略将共同决定其商业性和临床上的成败。支架设计、聚合物化学和生物界面技术的进步使得更具针对性和有效性的再生解决方案成为可能，而采购和监管压力则要求强有力的证据和成熟的营运流程。能够将科学创新与切实可行的生产製造、监管规划和临床医生合作相结合的机构，将更有利于将前景广阔的技术转化为持续的临床应用。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 开发患者特异性3D列印羟基磷灰石支架（梯度孔隙结构，促进骨整合）
  • 将载有BMP-2的奈米纤维聚合物支架整合到临界尺寸骨缺损修復中以达到可控释放
  • 干细胞封装可注射温敏水凝胶载体在微创骨再生的临床应用
  • 镁合金基可生物降解金属植入在承重整形外科应用的疗效检验
  • 用于齿槽脊增加手术的混合生物活性玻璃-胶原蛋白复合颗粒开始商业化
  • 用于持续释放成骨生长因子的介孔二氧化硅奈米颗粒递送系统的研究进展
  • 机器学习驱动设计平台的兴起：优化支架结构与材料组成
  • 用于脊椎融合手术的新一代间质干细胞支架获得监管部门核准
  • 拓展胶原蛋白包覆磷酸钙水泥糊剂在创伤治疗中快速局部骨缺损稳定的应用
  • 将氧化石墨烯增强材料整合到聚合物骨基质中，以提高其机械强度和生物性能。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依材料类型分類的骨再生材料市场

  • 陶瓷
    • 双相磷酸钙
    • 硫酸钙
    • 羟基磷灰石
    • 磷酸三钙
  • 复合材料
  • 金属
  • 自然生长因子
  • 聚合物
    • 胶原蛋白
    • 聚己内酯
    • Polyglycolic
    • 聚乳酸

第九章 骨再生材料市场：依应用领域划分

  • 牙科
    • 植入
    • 牙周组织缺损
    • 齿槽骨增容术
  • 整形外科
    • 骨缺损填充
    • 骨折固定
    • 关节重组
  • 脊椎
  • 创伤

第十章 依最终用户分類的骨再生材料市场

  • 门诊手术中心
  • 牙医诊所
  • 医院
    • 社区医院
    • 专科诊所
    • 大学医院
  • 研究所

第十一章 依供应类型分類的骨再生材料市场

  • 堵塞
  • 凝胶
  • 颗粒
    • 大孔颗粒
    • 微孔颗粒
  • 电影
  • 油灰
    • 注射用腻子
    • 可塑性油灰

第十二章 各地区骨再生材料市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 骨再生材料市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国骨再生材料市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Medtronic plc
    • Stryker Corporation
    • DePuy Synthes, Inc.
    • Zimmer Biomet Holdings, Inc.
    • Baxter International, Inc.
    • Orthofix Medical Inc.
    • Geistlich Pharma AG
    • BioHorizons IPH, Inc.
Product Code: MRR-1A1A064C0448

The Bone Regeneration Material Market is projected to grow by USD 11.15 billion at a CAGR of 7.97% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 6.03 billion
Estimated Year [2025] USD 6.52 billion
Forecast Year [2032] USD 11.15 billion
CAGR (%) 7.97%

A strategic introduction outlining the convergence of biomaterials innovation, clinical demands, regulatory challenges, and commercialization priorities in bone repair

Bone regeneration materials have evolved from rudimentary grafts and basic scaffolds into a nuanced portfolio of biomaterials, biologics, and delivery systems that address diverse clinical gaps across dental, orthopedic, spinal, and trauma care. The field is driven by converging technological advances in biomaterial science, biologic augmentation, and additive manufacturing, while clinicians increasingly demand predictable outcomes, lower complication rates, and streamlined workflows. Given the complex regulatory and reimbursement landscapes, developers must balance innovation with manufacturability and clinical evidence generation to achieve sustained adoption.

This introduction frames the strategic context for stakeholders evaluating product development, commercialization, procurement, or clinical adoption. It emphasizes the interplay between material characteristics, application-specific functional requirements, and end-user operational constraints. By clarifying key drivers such as osteoconductivity, osteoinductivity, handling properties, and supply chain resilience, this section sets expectations for subsequent analysis and identifies where targeted investments can yield disproportionate clinical and commercial returns. Ultimately, a pragmatic approach that integrates scientific rigor, clinician-centric design, and regulatory foresight will determine long-term success in this dynamic domain.

A clear exposition of the transformative technological, clinical, regulatory, and value-based shifts reshaping bone regeneration product development and adoption

The landscape for bone regeneration materials is undergoing transformative shifts as innovations in material chemistry, biologic augmentation, and precision manufacturing converge to redefine product capabilities and clinical workflows. Bioceramics and composite scaffolds now coexist with polymeric matrices and biologic enhancers, fostering hybrid solutions that aim to replicate the hierarchical structure and biological signaling of native bone. Simultaneously, additive manufacturing and patient-specific design enable anatomically matched implants and scaffolds that improve fit, reduce operative time, and support more predictable healing trajectories.

Beyond product-level innovation, there is a notable shift toward integrated care models where device performance, surgical technique, and post-operative management are considered holistically. Reimbursement pressures and value-based procurement are encouraging developers to demonstrate not only clinical efficacy but also reductions in downstream costs and improved patient-reported outcomes. Regulatory frameworks are also adapting to better accommodate combination products and advanced manufacturing approaches, prompting companies to invest earlier in regulatory science and robust clinical evidence. Collectively, these shifts are raising the bar for entry and rewarding organizations that can articulate clear clinical value and operational advantages.

An in-depth analysis of the multifaceted operational, clinical, regulatory, and supply chain consequences stemming from United States tariffs implemented in 2025

The imposition of additional tariffs in 2025 on certain medical materials and components has created a compound set of operational and strategic challenges for stakeholders across the bone regeneration value chain. At the operational level, manufacturers that rely on imported raw materials-such as high-purity ceramic powders, specific polymer feedstocks, or biologic reagents-face higher input costs and potential supplier reconfiguration. These pressures have prompted procurement teams to diversify supplier bases, consider re-shoring select capabilities, and re-negotiate long-term supplier agreements to secure continuity and predictable cost structures.

Clinically, the tariff-driven cost shifts can influence pricing strategies for advanced grafts and augmented products, which in turn may affect adoption in cost-sensitive settings. Hospitals and ambulatory centers under constrained budgets may favor solutions with lower acquisition costs or products that demonstrably shorten length of stay or reduce reoperation rates. In response, product developers have intensified dialogues with payers and hospital procurement to quantify value beyond unit price, emphasizing total episode-of-care benefits.

From an innovation standpoint, the tariffs have accelerated interest in localizing manufacturing of critical materials and expanding domestic capabilities for polymer synthesis, ceramic processing, and aseptic filling. This trend is accompanied by increased capital allocation toward process optimization, automation, and quality systems to offset higher unit costs with improved productivity. Regulatory implications are also material; manufacturers shifting production footprints must navigate multiple quality systems and regulatory notifications, which can extend timelines if not anticipated early.

Finally, the tariffs have heightened collaboration between manufacturers and supply chain partners to explore cost-sharing mechanisms, alternative formulations that reduce dependence on tariffed inputs, and pooled procurement strategies among healthcare networks. These initiatives aim to preserve patient access to advanced regenerative therapies while maintaining feasible commercial economics for developers and suppliers.

A comprehensive segmentation perspective linking material types, clinical applications, end-user settings, and delivery forms to inform product strategy and adoption pathways

Segmentation-driven insights reveal that material type, application, end-user context, and delivery form together define product performance requirements and commercialization pathways in bone regeneration. Based on material type, ceramic options such as hydroxyapatite, tricalcium phosphate, biphasic calcium phosphate, and calcium sulfate are prized for osteoconductivity and structural support, while composites integrate ceramic and polymer phases to balance mechanical behavior and bioactivity. Metals remain relevant where load-bearing strength is essential, and natural growth factors introduce biologic signaling to stimulate regeneration. Polymers offer tunable degradation and handling properties, with collagen, polycaprolactone, polyglycolic acid, and polylactic acid serving as key examples that influence cellular interaction and resorption profiles.

When viewed through applications, different clinical needs emerge across dental, orthopedic, spine, and trauma interventions. Dental use cases range from implantology to periodontal defect repair and ridge augmentation, each demanding precise handling and predictable volumetric stability. Orthopedic applications such as bone defect filling, fracture fixation, and joint reconstruction emphasize mechanical competence and long-term integration. Spine and trauma settings often require materials that can be delivered through minimally invasive approaches while supporting rapid structural recovery.

End-user segmentation further clarifies adoption dynamics; ambulatory surgical centers, dental clinics, hospitals, and research institutes each impose distinct operational constraints. Hospitals encompass community hospitals, specialty clinics, and university hospitals, and they bring differing procurement processes, clinical expertise, and infrastructure that affect which products gain traction. Delivery form is equally consequential: blocks, gels, granules, membranes, and putty offer varying trade-offs between handling, conformability, and osteoconductive surface area. Within granules, distinctions between macroporous and microporous architectures alter fluid exchange and cellular ingress, and putty options-injectable versus moldable-determine intraoperative versatility and suitability for minimally invasive procedures.

Taken together, these segmentation lenses underscore that successful product strategies must map material science to application-specific functional requirements, align delivery form with surgeon workflows, and tailor commercialization approaches to end-user procurement realities. This integrated perspective enables more targeted clinical studies, regulatory plans, and value propositions that resonate with decision-makers across the care continuum.

A detailed regional analysis highlighting differentiated clinical demand drivers, regulatory complexities, and supply chain strategies across global territories

Regional dynamics in bone regeneration display divergent drivers and barriers that shape technology adoption, regulatory navigation, and supply chain configuration. In the Americas, clinical demand is influenced by advanced surgical infrastructure and a high prevalence of elective procedures, creating a fertile environment for premium biomaterials and combination products, while payers and integrated delivery networks drive rigorous evidence expectations and cost-containment strategies. Europe, Middle East & Africa present a heterogeneous landscape where national reimbursement policies, centralized purchasing in some markets, and variable regulatory pathways create both opportunities and fragmentation; manufacturers often pursue targeted country strategies and partnerships to address this complexity.

Asia-Pacific exhibits rapid capacity expansion, an increasing number of trained specialists, and significant investments in domestic manufacturing, which together accelerate uptake of locally produced and internationally sourced innovations. Across regions, differences in clinical practice patterns, surgeon training, and health economic priorities necessitate customized market entry and post-market evidence plans. Additionally, regional supply chain resilience and sourcing strategies vary, prompting some developers to establish multi-regional manufacturing footprints or engage local contract manufacturers to ensure timely delivery and regulatory compliance. Recognizing these geographic nuances enables organizations to prioritize markets, sequence launches strategically, and adapt pricing and evidence generation to local expectations.

A synthesis of competitive dynamics, innovation strategies, and operational priorities that define leading companies and emerging challengers in bone regeneration materials

Competitive dynamics in bone regeneration are characterized by a mix of established biomaterials manufacturers, specialized medtech firms, and emerging biotechnology companies pursuing biologic augmentation and scaffold engineering. Leading organizations differentiate through integrated portfolios that combine proven scaffold platforms with biologic enhancers, proprietary processing technologies, and validated sterilization and packaging methods that preserve performance. Investment in manufacturing excellence, including quality management systems and scalable aseptic processes, is a recurring theme among companies seeking to move from niche products to broader, hospital-wide adoption.

Strategic collaborations and licensing arrangements are prevalent, enabling smaller innovators to access commercialization expertise and larger firms to incorporate novel science without assuming full early-stage development risk. Companies that invest in robust clinical evidence and publish peer-reviewed outcomes typically gain greater acceptance among key opinion leaders and hospital formularies. In parallel, nimble entrants leverage differentiated delivery forms-such as injectable putties or patient-specific 3D-printed scaffolds-to create procedural advantages. Intellectual property portfolios focused on material chemistries, surface modifications, and manufacturing methods often serve as critical defensive and value-enhancing assets.

Operational excellence, regulatory agility, and a clear articulation of value in terms of clinical outcomes and workflow efficiencies remain central to competitive success. Firms that align R&D priorities with real-world clinician needs and that proactively engage with payers and hospital procurement teams are better positioned to translate scientific innovation into durable commercial performance.

Actionable strategic recommendations that align material innovation, clinical evidence generation, supply chain resilience, and regulatory engagement for durable market advantage

Industry leaders should pursue a multi-pronged strategy that balances deep material science investment with pragmatic commercialization and supply chain resilience. First, prioritize development of hybrid solutions that combine favorable mechanical attributes with biologic signaling, focusing on platforms that can be adapted across multiple indications to maximize return on clinical evaluation. Simultaneously, invest in evidence generation that couples clinical outcomes with health economic endpoints, enabling stronger conversations with payers and hospital procurement to justify premium positioning based on total episode-of-care value.

Second, strengthen supply chain flexibility by diversifying raw material sources and evaluating regional manufacturing partnerships to mitigate tariff exposure and lead-time variability. Process optimization through automation and quality-by-design approaches can help lower per-unit manufacturing costs while preserving consistency and compliance. Third, engage early and continuously with regulatory authorities to clarify pathways for combination products and advanced manufacturing techniques, ensuring that technical files anticipate inspector expectations and streamline approvals.

Finally, cultivate clinician partnerships that inform product design and create credible clinical champions. Provide comprehensive training and case support to reduce adoption friction and collect real-world evidence that validates performance in typical practice settings. By executing these recommendations, organizations can enhance resilience, accelerate adoption, and sustain differentiation in an increasingly competitive and cost-conscious environment.

A transparent mixed-methods research framework combining primary clinical interviews, technical literature synthesis, and cross-functional validation to ensure actionable findings

The research methodology underpinning this analysis integrates primary and secondary research phases, expert interviews, and cross-functional validation to ensure balanced and actionable conclusions. Primary inputs comprised structured interviews with clinicians across dental, orthopedic, spine, and trauma specialties, procurement and supply chain leaders from hospitals and ambulatory centers, and regulatory and quality assurance specialists who provided insights into practical barriers and system-level considerations. These qualitative inputs were synthesized with technical literature, product filings, and public clinical studies to triangulate material performance characteristics and clinical outcomes.

Secondary analysis included a review of manufacturing technologies, material processing approaches, and regulatory guidance documents to contextualize product development risks and entry requirements. Comparative assessment of delivery forms and end-user workflows informed recommendations for handling and intraoperative use. Throughout the process, findings were iteratively validated with industry stakeholders to refine implications for commercialization, pricing strategy, and partnership models. This mixed-methods approach ensures that the insights presented reflect both technical realities and commercial constraints faced by decision-makers.

A conclusive synthesis emphasizing the need to integrate scientific innovation, operational excellence, and clinical evidence to achieve sustainable impact in bone regeneration

In closing, the field of bone regeneration materials sits at an inflection point where materials science, biologic augmentation, and supply chain strategy jointly determine commercial and clinical success. Advances in scaffold design, polymer chemistry, and biologic interfaces are enabling more targeted and effective regenerative solutions, while pressures from procurement and regulation demand robust evidence and operational maturity. Organizations that can harmonize scientific innovation with pragmatic manufacturing, regulatory planning, and clinician engagement will be best positioned to translate promising technologies into sustained clinical adoption.

Looking forward, success will favor those who can demonstrate not only superior biological performance but also clear advantages in handling, cost-efficiency across care episodes, and regulatory readiness. Strategic investments in diversified manufacturing, localized supply resilience, and outcome-focused evidence generation will mitigate external shocks and enable continued innovation. By adopting a multidisciplinary strategy that aligns R&D, clinical affairs, manufacturing, and commercial teams, stakeholders can accelerate the translation of next-generation bone regeneration materials into improved patient care and durable business outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Development of 3D printed patient-specific hydroxyapatite scaffolds with gradient porosity for enhanced osteointegration
  • 5.2. Integration of BMP-2 loaded nanofibrous polymeric scaffolds for controlled release in critical sized bone defect repair
  • 5.3. Clinical adoption of injectable thermosensitive hydrogel carriers with stem cell encapsulation for minimally invasive bone regeneration
  • 5.4. Validation of magnesium alloy based biodegradable metal implants for load bearing orthopedic applications
  • 5.5. Commercial launch of hybrid bioactive glass collagen composite granules for alveolar ridge augmentation procedures
  • 5.6. Advancements in mesoporous silica nanoparticle delivery systems for sustained osteogenic growth factor release
  • 5.7. Emergence of machine learning driven design platforms for optimizing scaffold architecture and material composition
  • 5.8. Regulatory approvals for next generation allogeneic mesenchymal stem cell scaffolds in spinal fusion surgeries
  • 5.9. Expansion of collagen coated calcium phosphate cement pastes for rapid in situ bone defect stabilization in trauma care
  • 5.10. Integration of graphene oxide reinforcement into polymeric bone matrices to enhance mechanical strength and biological performance

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bone Regeneration Material Market, by Material Type

  • 8.1. Ceramics
    • 8.1.1. Biphasic Calcium Phosphate
    • 8.1.2. Calcium Sulfate
    • 8.1.3. Hydroxyapatite
    • 8.1.4. Tricalcium Phosphate
  • 8.2. Composites
  • 8.3. Metals
  • 8.4. Natural Growth Factors
  • 8.5. Polymers
    • 8.5.1. Collagen
    • 8.5.2. Polycaprolactone
    • 8.5.3. Polyglycolic Acid
    • 8.5.4. Polylactic Acid

9. Bone Regeneration Material Market, by Application

  • 9.1. Dental
    • 9.1.1. Implantology
    • 9.1.2. Periodontal Defect
    • 9.1.3. Ridge Augmentation
  • 9.2. Orthopedic
    • 9.2.1. Bone Defect Filling
    • 9.2.2. Fracture Fixation
    • 9.2.3. Joint Reconstruction
  • 9.3. Spine
  • 9.4. Trauma

10. Bone Regeneration Material Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Dental Clinics
  • 10.3. Hospitals
    • 10.3.1. Community Hospitals
    • 10.3.2. Specialty Clinics
    • 10.3.3. University Hospitals
  • 10.4. Research Institutes

11. Bone Regeneration Material Market, by Delivery Form

  • 11.1. Blocks
  • 11.2. Gels
  • 11.3. Granules
    • 11.3.1. Macroporous Granules
    • 11.3.2. Microporous Granules
  • 11.4. Membranes
  • 11.5. Putty
    • 11.5.1. Injectable Putty
    • 11.5.2. Moldable Putty

12. Bone Regeneration Material Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Bone Regeneration Material Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Bone Regeneration Material Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Medtronic plc
    • 15.3.2. Stryker Corporation
    • 15.3.3. DePuy Synthes, Inc.
    • 15.3.4. Zimmer Biomet Holdings, Inc.
    • 15.3.5. Baxter International, Inc.
    • 15.3.6. Orthofix Medical Inc.
    • 15.3.7. Geistlich Pharma AG
    • 15.3.8. BioHorizons IPH, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DELIVERY FORM, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DELIVERY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BONE REGENERATION MATERIAL MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BONE REGENERATION MATERIAL MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. BONE REGENERATION MATERIAL MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BONE REGENERATION MATERIAL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BIPHASIC CALCIUM PHOSPHATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BIPHASIC CALCIUM PHOSPHATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BIPHASIC CALCIUM PHOSPHATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BIPHASIC CALCIUM PHOSPHATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BIPHASIC CALCIUM PHOSPHATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BIPHASIC CALCIUM PHOSPHATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CALCIUM SULFATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CALCIUM SULFATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CALCIUM SULFATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CALCIUM SULFATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CALCIUM SULFATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY CALCIUM SULFATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HYDROXYAPATITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HYDROXYAPATITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HYDROXYAPATITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HYDROXYAPATITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HYDROXYAPATITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HYDROXYAPATITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRICALCIUM PHOSPHATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMPOSITES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMPOSITES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMPOSITES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMPOSITES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMPOSITES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMPOSITES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY METALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY METALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY METALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY METALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY METALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY METALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY NATURAL GROWTH FACTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY NATURAL GROWTH FACTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY NATURAL GROWTH FACTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY NATURAL GROWTH FACTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY NATURAL GROWTH FACTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY NATURAL GROWTH FACTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COLLAGEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COLLAGEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COLLAGEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COLLAGEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COLLAGEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYCAPROLACTONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYCAPROLACTONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYCAPROLACTONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYCAPROLACTONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYLACTIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYLACTIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYLACTIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY POLYLACTIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY IMPLANTOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY IMPLANTOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY IMPLANTOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY IMPLANTOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY IMPLANTOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY IMPLANTOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PERIODONTAL DEFECT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PERIODONTAL DEFECT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PERIODONTAL DEFECT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PERIODONTAL DEFECT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PERIODONTAL DEFECT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PERIODONTAL DEFECT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RIDGE AUGMENTATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RIDGE AUGMENTATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RIDGE AUGMENTATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RIDGE AUGMENTATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RIDGE AUGMENTATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RIDGE AUGMENTATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BONE DEFECT FILLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BONE DEFECT FILLING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BONE DEFECT FILLING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BONE DEFECT FILLING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BONE DEFECT FILLING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BONE DEFECT FILLING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY JOINT RECONSTRUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY JOINT RECONSTRUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY JOINT RECONSTRUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY JOINT RECONSTRUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY JOINT RECONSTRUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRAUMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRAUMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRAUMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRAUMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRAUMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY TRAUMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY UNIVERSITY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY UNIVERSITY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY UNIVERSITY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY UNIVERSITY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY UNIVERSITY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY UNIVERSITY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DELIVERY FORM, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY DELIVERY FORM, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BLOCKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BLOCKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BLOCKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BLOCKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BLOCKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY BLOCKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GRANULES, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GRANULES, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GRANULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GRANULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GRANULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GRANULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GRANULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY GRANULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MACROPOROUS GRANULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MACROPOROUS GRANULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MACROPOROUS GRANULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MACROPOROUS GRANULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MACROPOROUS GRANULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MACROPOROUS GRANULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MICROPOROUS GRANULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MICROPOROUS GRANULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MICROPOROUS GRANULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MICROPOROUS GRANULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MICROPOROUS GRANULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MICROPOROUS GRANULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MEMBRANES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MEMBRANES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MEMBRANES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MEMBRANES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MEMBRANES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MEMBRANES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PUTTY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PUTTY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PUTTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PUTTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PUTTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PUTTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PUTTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY PUTTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY INJECTABLE PUTTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY INJECTABLE PUTTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY INJECTABLE PUTTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY INJECTABLE PUTTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY INJECTABLE PUTTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY INJECTABLE PUTTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MOLDABLE PUTTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MOLDABLE PUTTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MOLDABLE PUTTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MOLDABLE PUTTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MOLDABLE PUTTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY MOLDABLE PUTTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL BONE REGENERATION MATERIAL MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY DELIVERY FORM, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY DELIVERY FORM, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY GRANULES, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY GRANULES, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY PUTTY, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS BONE REGENERATION MATERIAL MARKET SIZE, BY PUTTY, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY CERAMICS, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY POLYMERS, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY DENTAL, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY ORTHOPEDIC, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA BONE REGENERATION MATERIAL MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MIL